Future Directions


Shout to the top! YOUNG LEADERS in diabetes find their VOICE

Over 50% of the world’s population is under 30. This group contribute around 5% to the global diabetes population – and their numbers are growing fast. Yet the needs of young people with diabetes often go unnoticed. Older generations overlook youth at our peril. In the words of Kofi Annan, “a society that cuts itself off from its youth severs its lifeline." Given the corrosive effects of inadequately managed diabetes on societies and economies worldwide, the need for diabetes advocacy involving an engaged and informed youth section has never been more important.

Fighting the fight for health and wellbeing – the Norwegian NCD Alliance

Working for a joint cause, collectively facing the same challenges, has been a uniting force for the Norwegian NCD Alliance. The Scandinavian allegiance was inspired by the global NCD Alliance founded by IDF . The links between diabetes and cardiovascular diseases have made cooperation between diabetes and heart organizations imperative. But bringing cancer and respiratory health into the campaign broke crucial new ground.

Setting the pace for comprehensive diabetes care in the East African Community

With the number of people living with diabetes estimated at 300 million worldwide and expected to increase to 500 million by 2030, there is an urgent need to act. As part of its plan to strengthen its Regions, the International Diabetes Federation encourages setting goals and targets based on regional needs. With economic development and rapid urbanization, African countries are witnessing a significant increase in the rates diabetes and other non-communicable diseases, such as cardiovascular diseases, chronic respiratory diseases and cancer.

The UN summit on NCDs: creating political momentum to save lives for diabetes

One of the first voices to call for a UN High-Level Meeting on NCDs, IDF has long recognized the need for a political platform to secure commitments and leadership at the highest level for diabetes. The global data on diabetes prevalence and costs presented in IDF’s Diabetes Atlas are critical to persuading policy makers of the need for urgent action to tackle the disease. Experience has shown, however, that even such robust evidence and dramatic numbers have not been enough to change hearts and minds and stimulate the increased investment required.

The role of research after the UN High-Level Meeting on NCDs

The new Diabetes Atlas, published recently by the IDF, confirms that the diabetes epidemic continues to worsen.

Building expertise in nutrition and behaviour in the Colombian Caribbean: promising advances against diabetes

Occupying in the northwest corner of South America, Colombia has borders with five countries, including Panama to the north and Brazil to the south, and a Caribbean as well as a Pacific coastline. Colombia, with 45 million inhabitants, has the second-largest population in South America and although it has one of the largest economies on the continent, inequality and unequal distribution of wealth are widespread. Around half the population lives under the poverty line.

A future of glucose-responsive insulin secretion: bionics versus nature

people with diabetes constantly walk a tight rope between strict glucose control to prevent complications and hypoglycaemia. Too often, slight miscalculations result in hypoglycaemia, which can be at best embarrassing and irritating, and may cause injury or even death.

Looking for new pharmacological treatments for type 2 diabetes

Type 2 diabetes is a heterogeneous disease characterized by multiple pathogenic defects. Impaired insulin secretion and insulin action (insulin resistance) are well-recognized major mechanisms contributing to the development of diabetes. In the past years, intensive research has much improved our understanding of the molecular mechanisms leading to defects of beta-cell function and impaired ability of insulin to promote glucose uptake in muscle and adipose tissue. More recently, other organs have been shown to play a role in the abnormalities of glucose homeostasis.

IDF first to address the question: is bariatric surgery good for diabetes?

Last year, ID F’s Taskforce on Epidemiology and Prevention of Diabetes convened a working group to review the role of surgery in the treatment and prevention of type 2 diabetes. Bariatric surgery, in which the gastrointestinal tract is operated on with the intention of achieving weight loss, has been shown to have significant metabolic benefit. In December last year, 20 people representing all the ID F regions, and different clinical disciplines, met at ID F’s headquarters to review the available evidence and consider the potential of the procedures for people with diabetes.

One Year to the UN's NCDs : IDF's roadmap

The countdown to the UN Summit on NC Ds has begun. With exactly one year to go, IDF launched the Diabetes Roadmap for the UN High-Level Summit on NCDs, which will ensure that this once-in-ageneration global platform moves the world from rhetoric to action on diabetes. Ann Keeling reports.